Tennis Elbow Treatment Market
Number of pages: 100 | Report Format: PDF | Published date: March 14, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
CAGR |
3.9% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023-2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Treatment Type, Patient Type, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global tennis elbow treatment market is expected to register a revenue CAGR of 3.9% during the forecast period.
Tennis Elbow Treatment Market Fundamentals
Tennis elbow is a disorder that causes discomfort and soreness in the outer elbow. It is also known as lateral epicondylitis. Overuse of the forearm muscles and tendons causes small cracks or rips in the tendons that connect to the lateral epicondyle of the humerus bone. Tennis elbow is a common ailment in athletes, such as tennis players, who constantly use their forearms. Still, this type of medical condition can also develop in persons that perform repeated gripping and twisting jobs, such as typing or using hand tools.
Due to aging, the tendons become less flexible and more prone to damage, increasing the chances of developing a tennis elbow. This medical condition can also be caused by a direct injury to the elbow, such as a fall or a strike. Different medical conditions, such as arthritis or nerve compression, can also contribute to the development of tennis elbow. Hence, tennis elbow is often treated with rest, ice, and nonsteroidal anti-inflammatory medications (NSAIDs) to relieve discomfort and inflammation. Physical therapy and exercises to strengthen and stretch the forearm muscles can also be advised by physicians. Corticosteroid injections or surgery may be required in extreme situations. If the discomfort persists or increases, it is critical to seek medical assistance since untreated tennis elbow can result in long-term impairment.
Tennis Elbow Treatment Market Dynamics
The increased prevalence of sports-related and tennis elbow injuries is the primary driver of the global market revenue growth. For instance, according to National Safety Council (NSC) Injury Statistics data, almost 3.2 million people were treated in the emergency room in July 2021 for injuries involving sports and leisure equipment, such as exercising, cycling, and basketball. Moreover, post-COVID-19 pandemic, there has been a relaxation in various lockdown regulations, which led to an increase in the number of sports activities globally. According to NSC injury statistics data, the prevalence of sports and leisure injuries increased by 20% in July 2021. This is predicted to raise the risk of tennis elbow injuries, driving the need for effective treatment and increasing market revenue. Additionally, a growing population suffering from severe elbow joint discomfort, a thriving healthcare sector globally, and increased expenditures in healthcare infrastructure are expected to drive the global tennis elbow treatment market. Together with these factors, increased awareness of tennis elbow treatment and management are likely to drive sales opportunities in the tennis elbow treatment market.
Pain in lateral epicondylitis (tennis elbow) progresses to severe circumstances, which can be managed further with non-steroidal anti-inflammatory drugs, such as ibuprofen and aspirin. Together with drugs, physiotherapies, such as muscle-activating methods and cold massage, aid in improving the illness. Aside from that, several straps and braces are available on the market to help restrict the stress on tendons and elbow muscles. These factors contribute to the revenue growth of the global market. Another factor driving the growth of the tennis elbow treatment market is the development and launch of painless treatment techniques for enhanced patient recovery. Transcatheter arterial embolization (TAE) and platelet-rich plasma (PRP) are two emerging sophisticated technologies for treating tennis elbow. TAE is a new therapy approach that uses ultrasound to treat the afflicted area. In contrast, PRP is a process that involves infusing the patient's platelets into the tendon to aid recovery. The alternative technique of treatment for tennis elbow is corticosteroid injection. These injections have little negative effects when used for a short period, but long-term usage can develop catastrophic repercussions.
However, the low adoption rate of novel effective medicines is projected to limit market revenue growth throughout the forecast period. Additionally, limited treatment options are available for tennis elbow, making it difficult for healthcare providers to manage the condition effectively. The lack of a standardized approach for treating tennis elbow with poor patient compliance can also create hurdles in market revenue growth. Moreover, the high cost of treatment, long recovery time, and high recurrence rate can hamper the global market expansion.
Tennis Elbow Treatment Market Ecosystem
The global tennis elbow treatment market has been analyzed from three perspectives: treatment type, patient type, and region.
Tennis Elbow Treatment Market by Treatment Type
[56745]
Based on the treatment type, the global tennis elbow treatment market can be further segmented into surgical therapies and non-surgical therapies.
The non-surgical treatment segment accounts for the largest revenue share in the global market in 2022. Most patients prefer non-surgical treatments as they are less invasive and carry lower risks and complications than surgical procedures. Non-surgical treatments, such as physical therapy, extracorporeal shock wave therapy, medications, and braces, can effectively treat tennis elbow without surgery. Additionally, this treatment method is comparatively more cost-effective than surgical treatment, making them a more affordable option for patients. Patients who undergo non-surgical treatments can often return to normal activities more quickly than those who have surgery. Moreover, this treatment for tennis elbow is highly effective, with a success rate of up to 80%, and can also be performed in outpatient settings.
The medication segment is highly preferred for tennis elbow treatment among non-surgical treatment methods. Medications such as NSAIDs, corticosteroids, hyaluronic acid (HA), and botulinum toxin (Botox) are widely utilized. NSAIDs such as ibuprofen, naproxen, and aspirin are commonly used to relieve pain and reduce inflammation in the elbow joint. Moreover, topical creams containing NSAIDs or other pain-relieving agents can also be applied directly to the skin over the affected area to relieve pain and inflammation. Corticosteroids are powerful anti-inflammatory medications that can be injected directly into the affected elbow joint area to relieve pain and inflammation. Similarly, HA is a naturally occurring substance in the body that helps to lubricate and cushion the joints. Injecting HA into the affected elbow joint area can help reduce pain and improve joint function. Furthermore, Botox injections have been used to treat tennis elbow by relaxing the muscles and reducing tension in the affected area of the elbow joint.
Most patients with tennis elbow do not prefer the surgical method; however, surgical intervention can be an effective solution for individuals with unsuccessful results in other treatments. Surgery often entails the removal of damaged tissue, which is subsequently replaced with fresh and healthy tissue. Two approaches are in use, both conducted as outpatient operations. These surgical approaches include open surgery and arthroscopy, conducted with a major incision into the elbow or using multiple tools introduced via smaller incisions. In the weeks and months following surgery, rehabilitation treatment is frequently necessary. Arthroscopic surgery utilizes a tiny incision in the skin, resulting in less tissue injury and a decreased risk of infection and scarring. Patients often feel less pain and suffering during and after arthroscopic surgery as it is less intrusive than standard open surgery. Furthermore, arthroscopic surgery often requires less time to recuperate than standard open surgery, allowing patients to resume regular activities sooner.
Tennis Elbow Treatment Market by Patient Type
Based on the patient type, the global tennis elbow treatment market can be further segmented into children and adults.
The adult segment dominates the global tennis elbow treatment market with the largest revenue share. Tennis elbow comparatively affects more adults than children for a variety of reasons. People prefer to participate in activities that require repetitive gripping and twisting actions, putting strain on the forearm muscles, such as playing tennis or golf or utilizing tools. Moreover, children are comparatively less likely to participate in high-intensity or frequent participation in these sorts of activities. In addition, adults use their arms and hands longer, resulting in more wear and strain on their muscles, tendons, and bones. As a result, they can be predisposed to develop tennis elbow. Furthermore, due to active growth and development, children have a larger ability for healing and regeneration. This implies that if infants sustain small injuries, their bodies may be able to mend them faster than adults. While adults, on the other hand, can recover more slowly, leading to chronic symptoms of tennis elbow.
Tennis Elbow Treatment Market by Region
The global tennis elbow treatment market can be further segmented based on the region into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
In terms of revenue share, North America led the global tennis elbow treatment market in 2022. The growing number of sporting events and competitions in the United States and the rising patient awareness are crucial factors driving the revenue growth of the tennis elbow treatment market in this region. Additionally, the rapidly growing elderly population and favorable reimbursement policies are expected to boost regional demand. Moreover, the presence of prominent players in the region is also a significant factor driving the revenue growth of the North America tennis elbow treatment market.
Asia Pacific is the fastest growing region in the global market, attributed to the rising prevalence of tennis elbow due to rising cases of athletic accidents and growing awareness of tennis elbow among the population. Additionally, the growing adoption of advanced technologies and emerging healthcare infrastructure contribute to the revenue growth of this region's tennis elbow treatment market.
Tennis Elbow Treatment Market Competitive Landscape
The key market companies offer a broad range of medical products and equipment for treating tennis elbow. An increase in operational performance, presence in international markets, and focus on R&D activities are the major strengths of these companies. Product defects and infringement issues are the key concerns for the company hampering its market revenue growth. Intense competition and stringent regulations could also affect the financial condition adversely. However, companies may find opportunities through business acquisitions, product approvals, and strategic developments.
The prominent players operating in the global tennis elbow treatment market are:
Tennis Elbow Treatment Market Strategic Developments
The global tennis elbow treatment market is expected to grow at a revenue CAGR of 3.9% during the forecast period from 2023 to 2031.
The non-surgical segment dominates the market with the largest revenue share.
Limited treatment options for tennis elbow and the low adoption rate for the treatments further restrain the global market revenue growth.
North America is expected to show lucrative growth in the global market with the largest revenue share.
3M Co, Teikoku Pharma USA Inc, Veritas Health LLC, and Ossur Corporate are among the top players in the global tennis elbow treatment market.
*Insights on financial performance are subject to the availability of information in the public domain